Y. Choi

27.0k total citations · 3 hit papers
128 papers, 6.0k citations indexed

About

Y. Choi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Y. Choi has authored 128 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Oncology, 66 papers in Pulmonary and Respiratory Medicine and 34 papers in Molecular Biology. Recurrent topics in Y. Choi's work include Gastric Cancer Management and Outcomes (49 papers), Colorectal Cancer Treatments and Studies (34 papers) and Lung Cancer Treatments and Mutations (20 papers). Y. Choi is often cited by papers focused on Gastric Cancer Management and Outcomes (49 papers), Colorectal Cancer Treatments and Studies (34 papers) and Lung Cancer Treatments and Mutations (20 papers). Y. Choi collaborates with scholars based in South Korea, United States and United Kingdom. Y. Choi's co-authors include Yeul Hong Kim, Sung Hoon Noh, Yung‐Jue Bang, Hyun Cheol Chung, Keun‐Wook Lee, Kyung Hee Lee, Jae Yun Lim, Peter Button, Yong Ho Kim and Young Kyu Park and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Y. Choi

124 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

2012 1.2k citations Yung‐Jue Bang, Hyun Cheol Chung et al. profile →
Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600–Mutant Anaplastic Thyroid Cancer

2017 607 citations Vivek Subbiah, Robert J. Kreitman et al. Journal of Clinical Oncology profile →
Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study

2022 183 citations Vivek Subbiah, Robert J. Kreitman et al. Annals of Oncology profile →

Peers

Countries citing papers authored by Y. Choi

Since Specialization

Citations

This map shows the geographic impact of Y. Choi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Choi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Choi more than expected).

Fields of papers citing papers by Y. Choi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. Choi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Choi. The network helps show where Y. Choi may publish in the future.

Co-authorship network of co-authors of Y. Choi

This figure shows the co-authorship network connecting the top 25 collaborators of Y. Choi. A scholar is included among the top collaborators of Y. Choi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. Choi. Y. Choi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adenocarcinoma having high serum eotaxin levels (KG4/2015): an open-label, randomised, Phase 3 trial 2023 ·British Journal of Cancer ·Jung Hyun Jo, Yong‐Tae Kim, Ho Soon Choi, Ho Gak Kim, Hong Sik Lee, Young Woo Choi, Dong Uk Kim, Kwang Hyuck Lee, Eui Joo Kim, Joung‐Ho Han, Seung Ok Lee, Chang‐Hwan Park, Eun Kwang Choi, Jae Woo Kim, Y. Choi, Woo Jin Lee, Hyungsik Roger Moon, Mi‐Suk Park, (unknown), Si Young Song	14
2	Global loss of cellular m ⁶ A RNA methylation following infection with different SARS-CoV-2 variants 2023 ·Genome Research ·Roshan Vaid, (unknown), (unknown), Rebeca Burgos‐Panadero, Rémy Robinot, Bárbara F. Fonseca, Nikhil R. Gandasi, Johan Ringlander, Mohammad Hassan Baig, Jae-June Dong, Y. Choi, Björn Reinius, Lisa A. Chakrabarti, Kristina Nystrôm, Tanmoy Mondal	18
3	1518P Zanidatamab (zani) plus chemotherapy (chemo) and tislelizumab (tis) as first-line (1l) therapy for patients (pts) with advanced HER2-positive (+) gastric/gastroesophageal junction adenocarcinoma (GC/GEJC): Updated results from a phase Ib/II study 2023 ·Annals of Oncology ·Kyung-Woo Lee, (unknown), Minkyu Jung, Jieer Ying, Y-H Im, D-Y. Oh, Y. Choi, Sang Cheul Oh, Yee Chao, (unknown), (unknown), (unknown)	6
4	Identification of Potential Genomic Alterations Using Pan-Cancer Cell-Free DNA Next-Generation Sequencing in Patients With Gastric Cancer 2023 ·Annals of Laboratory Medicine ·(unknown), Yoonjung Kim, Y. Choi, Kyung‐A Lee	3
5	A phase I/II study of poziotinib combined with paclitaxel and trastuzumab in patients with HER2-positive advanced gastric cancer 2019 ·Gastric Cancer ·Tae Yong Kim, Hye Sook Han, Keun‐Wook Lee, Dae Young Zang, Sun Young Rha, Young Iee Park, Jin Soo Kim, Kyung-Hun Lee, Se Hoon Park, Eun‐Kee Song, (unknown), (unknown), Yeul Hong Kim, Y. Choi, Yung‐Jue Bang	32
6	Updated efficacy and safety data of dabrafenib (D) and trametinib (T) in patients (pts) with BRAF V600E–mutated anaplastic thyroid cancer (ATC) 2018 ·Annals of Oncology ·Bhumsuk Keam, Robert J. Kreitman, Zev A. Wainberg, Maria E. Cabanillas, (unknown), Antoîne Italiano, Alexander Stein, Y. Choi, Jan H.M. Schellens, Patrick Y. Wen, C. C. Zielinski, Aislyn Boran, Bijoyesh Mookerjee, (unknown), Fatima Rangwala, Vivek Subbiah	11
7	Efficacy of Sequential Ipilimumab Monotherapy versus Best Supportive Care for Unresectable Locally Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer 2017 ·Clinical Cancer Research ·Yung‐Jue Bang, Y. Choi, Yeul Hong Kim, Jin Won Kim, Maria Di Bartolomeo, Jaffer A. Ajani, Kensei Yamaguchi, Ágnes Balogh, Teresa Sánchez, Markus Moehler	113
8	Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600–Mutant Anaplastic Thyroid Cancer breakdown → 2017 ·Journal of Clinical Oncology ·Vivek Subbiah, Robert J. Kreitman, Zev A. Wainberg, Y. Choi, Jan H.M. Schellens, Jean Charles Soria, Patrick Y. Wen, Christoph Zielinski, Maria E. Cabanillas, Gladys Urbanowitz, Bijoyesh Mookerjee, (unknown), Fatima Rangwala, Bhumsuk Keam	607
9	Phase II trial of dacomitinib in patients with HER2-positive gastric cancer 2015 ·Gastric Cancer ·Do‐Youn Oh, (unknown), Y. Choi, Won Ki Kang, Seock‐Ah Im, Jin Won Kim, Yung‐Jue Bang	35
10	Gemcitabine Combined with Capecitabine Compared to Gemcitabine with or without Erlotinib as First-Line Chemotherapy in Patients with Advanced Pancreatic Cancer 2014 ·Cancer Research and Treatment ·Jae Yun Lim, Jang Ho Cho, Se Joon Lee, Dong Ki Lee, Dong Sup Yoon, Y. Choi	10
11	AMPKα Modulation in Cancer Progression: Multilayer Integrative Analysis of the Whole Transcriptome in Asian Gastric Cancer 2012 ·Cancer Research ·Yon Hui Kim, Han Liang, Xiuping Liu, Ju‐Seog Lee, Y. Choi, Jae‐Ho Cheong, Hoguen Kim, Min Li, Thomas J. Downey, Matthew D. Dyer, Yongming Sun, (unknown), Ellen M. Beasley, Hyun Cheol Chung, Sung Hoon Noh, John N. Weinstein, Chang‐Gong Liu, Garth Powis	79
12	On the Decentralized H2 Optimal Control of Bilateral Teleoperation Systems with Time Delays 2012 ·Lund University Publications (Lund University) ·(unknown), Y. Choi	11
13	Gene Expression Signature–Based Prognostic Risk Score in Gastric Cancer 2011 ·Clinical Cancer Research ·Y. Choi, Jae Yun Lim, Jae‐Ho Cheong, Yun‐Yong Park, (unknown), Soo Mi Kim, Sang-Bae Kim, Hoguen Kim, Soon Won Hong, Young Nyun Park, Sung Hoon Noh, Eun Sung Park, In‐Sun Chu, Waun Ki Hong, Jaffer A. Ajani, Ju‐Seog Lee	269
14	Gene Expression Signature Analysis Identifies Vorinostat as a Candidate Therapy for Gastric Cancer 2011 ·PLoS ONE ·Sofie Claerhout, Jae Yun Lim, Woonyoung Choi, (unknown), Kyounghyun Kim, Sang-Bae Kim, Ju‐Seog Lee, Gordon B. Mills, Y. Choi	99
15	Prognostic Biomarkers for Esophageal Adenocarcinoma Identified by Analysis of Tumor Transcriptome 2010 ·PLoS ONE ·Soo Mi Kim, (unknown), Eun Sung Park, Y. Choi, Julie Izzo, Di Zhang, Sang-Bae Kim, Jeffrey H. Lee, Manoop S. Bhutani, Stephen G. Swisher, Xifeng Wu, Kevin R. Coombes, Dipen M. Maru, Kenneth K. Wang, Navtej Buttar, Jaffer A. Ajani, (unknown), (unknown)	115
16	Erlotinib Monotherapy for Stage IIIB/IV Non-small Cell Lung Cancer: A Multicenter Trial by the Korean Cancer Study Group 2009 ·Journal of Thoracic Oncology ·Ji Eun Uhm, (unknown), Myung‐Ju Ahn, Jeeyun Lee, Jin Seok Ahn, (unknown), Heung-Tae Kim, (unknown), Jin‐Hyoung Kang, Y. Choi, Hong Song, Se Hoon Park, (unknown), Sang Won Shin, (unknown), Keunchil Park	24
17	Salvage Chemotherapy with Docetaxel and Epirubicin for Advanced/Metastatic Gastric Cancer 2007 ·Oncology ·Jae Yun Lim, Y. Choi, Yong Han Paik, Dong Ki Lee, Sang In Lee, Hyojin Park, Se Joon Lee, Kwan Sik Lee, Dong Sup Yoon, Seung Ho Choi	5
18	Articles : A Modified PCR-Directed Gene Replacements Method Using λ-Red Recombination Functions in Escherichia coli 2005 ·Journal of Microbiology and Biotechnology ·Sang-Yoon Kim, Y. Choi	5
19	Phase II Study of Topotecan and Etoposide as Second-line Treatment in Chemotherapy-refractory Small-cell Lung Cancer 2002 ·Cancer Research and Treatment ·Chul Kim, Joohyuk Sohn, Joo Hang Kim, Soon Il Kim, Young Sam Kim, Joon Chang, Y. Choi	2
20	Overexpression of c-ErbB-2 Protein in Gastric Cancer by Immunohistochemical Stain 1996 ·Oncology ·(unknown), Joo-Hang Kim, (unknown), Joong Bae Ahn, Sun Young Rha, Y. Choi, Jong In Lee, (unknown), Hyun Cheol Chung, (unknown), Jin Sik Min, Kyong Sik Lee, Dong Hwan Shin, Byung‐Soo Kim, Soon Won Hong, (unknown)	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact